Telehealth Insomnia Prescribing: What Psychiatrists Can Do in New York

You’re seeing patients who can’t sleep. They’re tired of scrolling through their phone at 3 AM, trying to function on four hours of fragmented rest, and they’re asking for help. As a psychiatric prescriber, you know insomnia is rarely just about sleep — it’s tangled up with anxiety, depression, circadian rhythm chaos, and sometimes medical conditions you can’t manage alone.

But here’s the practical question: Can you actually prescribe insomnia medication via telehealth?

The short answer: Yes — with some caveats.

As of early 2026, both psychiatrists and PMHNPs can legally prescribe insomnia medications via telehealth in most states, including controlled substances like zolpidem (Ambien) or eszopiclone (Lunesta). The DEA extended pandemic-era flexibilities through December 31, 2025, allowing prescribers to initiate controlled medications remotely without a prior in-person visit. While that deadline has passed, enforcement remains flexible as regulators finalize permanent telemedicine rules. For now, you can prescribe sleep meds via video visits if you’re licensed in the patient’s state and follow standard clinical protocols.

But the real complexity isn’t federal law — it’s the state-by-state patchwork of scope of practice rules, prescribing limits, and telehealth regulations that determine whether you can practice independently or need physician oversight, and whether your prescriptions have duration caps or formulary restrictions.

Let’s break down what you actually need to know to manage insomnia via telehealth without running into regulatory landmines.

Who Can Prescribe Insomnia Meds via Telehealth? Psychiatrists vs PMHNPs

Psychiatrists: Full Authority, Minimal Barriers

If you’re a licensed psychiatrist (MD or DO), the regulatory landscape is straightforward. You have full prescribing authority in every state where you hold an active medical license. You can:

• Diagnose insomnia via telehealth (video required for controlled substances in most cases)
• Prescribe any medication indicated for insomnia — Schedule II through V controlled substances, off-label sedatives, whatever’s clinically appropriate
• Practice independently without supervision requirements
• Order sleep studies or coordinate with sleep specialists as needed

The only hard rule: You must be licensed in the state where the patient is physically located during the telehealth visit. If you’re treating a patient in Texas while they’re on vacation in Florida, you need a Florida license for that encounter.

Some states make multi-state licensure easier. Texas and Illinois participate in the Interstate Medical Licensure Compact (IMLC), which streamlines the application process if you’re already licensed in another compact state. California, New York, Florida, and Pennsylvania are not in the compact (yet), so you’ll need to apply for full licensure in each state individually.

Bottom line for psychiatrists: If you’re licensed in the state, you can prescribe insomnia meds via telehealth with the same authority you’d have in an office. No physician oversight, no special approvals, no duration caps beyond clinical judgment.

PMHNPs: It Depends on Your State (and Experience Level)

For psychiatric nurse practitioners, prescribing authority varies wildly by state. Some states treat experienced PMHNPs almost identically to psychiatrists. Others require physician oversight for every prescription.

Here’s the breakdown:

Full Practice Authority States:In states with full practice authority (FPA), experienced PMHNPs can evaluate, diagnose, and prescribe controlled substances independently — no physician collaboration agreement required.

• New York: After 3,600 hours of clinical practice (roughly 2 years full-time), PMHNPs can practice completely independently. No written agreement, no chart reviews, no physician sign-off needed. You can prescribe zolpidem, temazepam, or any other insomnia medication within your scope.

• California: The AB 890 pathway allows PMHNPs to transition from supervised practice (working in a physician-led group as a ‘103 NP’) to fully independent practice after three years (becoming a ‘104 NP’ by 2026). Once you reach 104 status, you can prescribe insomnia meds solo within your psychiatric specialty.

• Illinois: PMHNPs can achieve full practice authority after completing 4,000 hours under a collaborative agreement plus 250 hours of continuing education. Once you hit FPA status, you prescribe independently (though IL law technically requires physician consultation if you’re prescribing Schedule II drugs for more than 30 days — rarely relevant for insomnia).

In these states, an experienced PMHNP treating insomnia via telehealth operates nearly identically to a psychiatrist.

Reduced Practice Authority States:These states require a collaborative agreement with a physician, but the oversight is limited — usually written protocols and periodic chart reviews rather than day-to-day supervision.

• New York (early-career NPs): If you have fewer than 3,600 hours, you need a written collaborative agreement with a supervising physician. The physician doesn’t see your patients or approve every prescription, but you must have the formal relationship in place.

• Illinois (pre-FPA): Before achieving independent status, Illinois PMHNPs must have a collaborating physician who delegates prescriptive authority. The physician reviews a percentage of charts periodically.

Restricted Practice Authority States:In these states, PMHNPs face the most barriers: ongoing physician supervision, prescribing limits, and administrative overhead.

• Texas: PMHNPs must have a Prescriptive Authority Agreement with a Texas physician. The agreement must include at least monthly quality assurance meetings and chart reviews. Physicians can supervise up to seven NP/PA providers. Texas also bans NPs from prescribing Schedule II controlled substances in outpatient settings — though most insomnia meds (Ambien, Lunesta, temazepam) are Schedule IV, so this rarely impacts sleep medicine. The real headache is the monthly meetings and paperwork.

• Florida: Psychiatric NPs are excluded from Florida’s autonomous practice law, meaning you need a supervising physician and written protocol no matter how experienced you are. Florida also limits NPs to a 7-day supply of Schedule II meds (though again, most insomnia drugs are Schedule IV). A Florida PMHNP can prescribe sleep meds via telehealth, but only under physician supervision.

• Pennsylvania: PMHNPs must have a collaborative agreement with two physicians (yes, two). Pennsylvania also caps prescribing: NPs cannot prescribe more than a 30-day supply of Schedule II or more than a 90-day supply of Schedule III/IV without physician reevaluation. For a chronic insomnia patient on Ambien, this means you’ll need the supervising physician to review and approve continuation every three months.

What This Means for Your Practice:

If you’re a PMHNP considering telehealth insomnia work, your state’s scope of practice determines whether you can:

• Practice solo or need to secure a supervising physician (which some telehealth platforms provide)
• Prescribe without duration caps or face mandatory physician reviews after 30-90 days
• Treat patients independently or work under protocols that add administrative friction

The good news: Even in restricted states, you can prescribe insomnia meds via telehealth. You just need the right infrastructure (a collaborating physician, compliant protocols) in place.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Rules: Can You Actually Prescribe Controlled Substances Remotely?

Most insomnia medications — zolpidem (Ambien), eszopiclone (Lunesta), temazepam (Restoril), zaleplon (Sonata) — are Schedule IV controlled substances. Historically, the Ryan Haight Act required an in-person medical evaluation before prescribing any controlled substance via telemedicine.

COVID changed everything.

During the pandemic, the DEA waived the in-person requirement, allowing providers to prescribe controlled substances via telehealth without ever meeting the patient face-to-face. That waiver was extended multiple times — most recently through December 31, 2025.

As of early 2026, we’re in a gray zone. The formal extension has expired, but enforcement remains flexible while the DEA finalizes permanent telemedicine prescribing rules. In practice, this means:

• You can still prescribe Schedule IV insomnia meds via telehealth (video visit required)
• An initial in-person visit is not currently being enforced as a hard requirement
• The DEA is expected to issue final rules sometime in 2026, which may introduce new requirements (such as a mandatory in-person visit within 6-12 months for ongoing controlled substance prescriptions, or a special telemedicine DEA registration)

What you should do now:

1. Conduct video visits (not audio-only) for any controlled substance prescription. Audio-only telehealth is not considered sufficient for initiating controlled meds under most state standards of care.

2. Document thoroughly: Note that the visit was via telemedicine, the patient’s location, and your clinical rationale for prescribing.

3. Follow state PDMP requirements: Nearly every state requires checking the Prescription Drug Monitoring Program database before prescribing controlled substances. Texas mandates PDMP checks for benzodiazepines and opioids. New York requires checking the I-STOP database for every Schedule II-IV prescription. Illinois focuses on opioids and benzos but best practice is to check for all controlled meds.

4. Stay updated: The regulatory landscape is evolving. The DEA could require an in-person visit by mid-2026. Subscribe to updates from your state medical board, DEA, and telehealth advocacy groups like the Center for Connected Health Policy (CCHP).

The practical reality: As of now, you can prescribe insomnia meds via telehealth without an in-person visit. Just be prepared for potential rule changes and ensure your platform has compliance systems in place.

State-Specific Telehealth Rules You Need to Know

Beyond scope of practice, individual states have telehealth-specific laws that affect how you deliver care and get paid.

Licensure and Out-of-State Practice

Florida allows out-of-state providers to register as telehealth providers without obtaining full Florida licensure. If you’re licensed in another state with no recent disciplinary action, you can register with the Florida Department of Health and treat Florida patients via telemedicine. You cannot open a physical clinic in Florida under this registration, but you can prescribe and bill for virtual visits.

Texas recently passed HB 1052 (effective January 2026), which requires insurers to cover telehealth services delivered from out-of-state as long as the provider holds a Texas license. This doesn’t waive the licensure requirement, but it does clarify that you can physically be anywhere while treating Texas patients — you just need the Texas license and a business address in Texas.

Most other states (California, New York, Pennsylvania, Illinois) require full in-state licensure to practice via telehealth. Some have temporary telehealth registrations during emergencies, but those have largely expired post-pandemic.

Prescribing-Specific State Rules

Florida: You cannot prescribe Schedule II controlled substances via telehealth except for psychiatric use, inpatient care, hospice, or nursing home residents. Since insomnia is considered a psychiatric condition, you’re allowed to prescribe stimulants (for comorbid narcolepsy, for example) or other Schedule II meds if clinically indicated. Schedule IV sleep meds (Ambien, Lunesta) are fine via telehealth with no special restrictions.

Pennsylvania: No specific telehealth prescribing bans, but the 30-day Schedule II / 90-day Schedule III-IV caps for NPs apply regardless of visit modality.

Texas: Requires establishing a valid patient-practitioner relationship via an appropriate telehealth exam before prescribing controlled substances. This is standard practice everywhere, but Texas explicitly codifies it. You must have a real-time audio-video interaction (not asynchronous messaging) and document the clinical encounter.

Payment Parity and Reimbursement

24 states (including California, New York, Illinois, and Texas) have laws requiring private insurers to cover telehealth services at the same rate as in-person visits. This is huge for your bottom line — it means you can’t be paid less just because you’re delivering care via video.

Medicare reimburses tele-psychiatry visits at the same rate as office visits, and Congress has repeatedly extended telehealth flexibilities for mental health services. As of 2026, Medicare is expected to continue covering telehealth mental health visits without requiring an annual in-person visit (though this was initially planned, enforcement has been delayed).

What you can bill:

For a 20-minute medication management visit (established patient), expect to bill CPT 99213 (~$95 Medicare national average). For a 30-minute visit, CPT 99214 (~$125). Private insurance rates often exceed Medicare rates, especially for psychiatry given the provider shortage.

If you combine brief therapy with medication management (e.g., discussing sleep hygiene techniques while adjusting Ambien dosage), you might use a psychotherapy add-on code, though most insomnia med checks are coded as pure E/M visits.

Bottom line: Financially, telehealth insomnia care is viable. You’ll be paid fairly, especially in states with parity laws, and the convenience factor (no commute, flexible scheduling) attracts patients willing to pay cash if you go that route.

The Economics of Telehealth Insomnia Care: Platform vs DIY

Let’s talk money.

If you’re considering joining a telehealth platform like Klarity Health versus building your own practice, you need to understand the real cost of patient acquisition.

The Hidden Cost of DIY Marketing

Many providers assume they can quickly build a patient panel through Google Ads, SEO, or directory listings like Psychology Today. The reality is far more expensive and time-consuming than most expect.

Google Ads for mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through paid search is $200-400+ when you factor in:

• Ad spend testing and optimization
• Agency or consultant fees (if you’re not running campaigns yourself)
• Staff time to answer inquiries and qualify leads
• No-show rates from cold leads who haven’t been vetted

SEO takes 6-12 months of consistent investment (content creation, technical optimization, link building) before generating meaningful patient flow. Unless you have expertise in healthcare SEO or budget to hire an agency ($2,000-5,000/month), you’re gambling on uncertain results.

Directory listings (Psychology Today, Zocdoc) charge monthly fees and you compete with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking, and you’re still paying the monthly platform subscription fee on top of that.

Total monthly DIY marketing spend for a solo provider trying to build a caseload: easily $3,000-5,000/month with no guaranteed ROI. You might spend six months and $20,000 before seeing consistent patient flow.

The Klarity Model: Pay-Per-Appointment Economics

Klarity Health uses a pay-per-appointment model similar to Zocdoc, but with a critical difference: patients are pre-qualified and matched to your specialty and availability before you see them.

How it works:

• No upfront marketing spend or monthly subscription fees
• You pay a standard listing fee per new patient lead (competitive with industry norms)
• Patients are already screened for insurance eligibility and clinical appropriateness
• You control your schedule — only pay when you actually see patients
• Built-in telehealth infrastructure (no separate EMR/platform costs)
• Mix of insurance and cash-pay patients depending on your preferences

The value proposition: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels that may or may not convert.

For a provider starting out or scaling up, this removes the biggest risk: wasting money on patient acquisition that doesn’t work.

When DIY makes sense:

If you have an established practice, existing patient referrals, and the budget/expertise to invest in long-term marketing (SEO, content, reputation management), DIY patient acquisition can eventually be cost-effective. But for most providers — especially those building a telehealth panel from scratch — the platform model eliminates financial risk entirely.

Insomnia Prescribing: How It’s Different from Other Psychiatric Care

Managing insomnia via telehealth isn’t just ‘prescribe Ambien and follow up in a month.’ It requires a different clinical and regulatory mindset than treating depression, anxiety, or ADHD.

Behavioral Therapy Is First-Line (Not Medication)

Clinical guidelines recommend Cognitive Behavioral Therapy for Insomnia (CBT-I) as first-line treatment, with pharmacotherapy reserved for short-term use or when CBT-I fails. This creates a workflow challenge: ideally, you’re prescribing sleep meds as a bridge while the patient accesses CBT-I (either through you, a therapist referral, or a digital CBT-I app).

In practice, many patients want pills now and aren’t interested in six weeks of sleep restriction therapy. You’ll need to balance evidence-based care with patient preferences while documenting your rationale.

Tolerance and Dependence Concerns

Unlike SSRIs (which you prescribe indefinitely for depression), insomnia meds carry risk of tolerance, dependence, and rebound insomnia when stopped abruptly. This means:

• Shorter prescription durations (30 days initially, not 90)
• More frequent follow-ups (every 2-4 weeks early on)
• Explicit discussions about tapering and discontinuation plans
• Monitoring for misuse (especially with benzodiazepines like temazepam)

You’ll also encounter patients who’ve been on Ambien for years and want refills without addressing underlying causes. Navigating that conversation (‘Let’s talk about why you’re still not sleeping after five years on zolpidem’) is part of the job.

Ruling Out Medical Causes

Insomnia can be secondary to sleep apnea, restless legs syndrome, chronic pain, hyperthyroidism, or medication side effects. Unlike pure psychiatric conditions where you’re treating the brain chemistry, insomnia often requires coordination with primary care or sleep specialists.

Via telehealth, you can’t do a physical exam. You’ll rely on:

• Detailed history (sleep diary, Epworth Sleepiness Scale, STOP-BANG for apnea risk)
• Patient-reported symptoms (snoring, witnessed apneas, leg jerking)
• Referrals for in-person sleep studies if red flags emerge

If you suspect sleep apnea, you’re not prescribing a hypnotic — you’re referring for polysomnography and potentially CPAP therapy. Telehealth allows you to triage and coordinate, but you can’t replace all in-person diagnostics.

Insurance and Prior Authorization Hassles

Many insurers limit controlled sleep meds to 30 days or require prior authorization after a certain duration. They may also mandate trial of non-controlled alternatives (trazodone, doxepin, melatonin) before approving zolpidem.

Telehealth doesn’t change this, but it does make the administrative workflow easier if your platform handles PA requests or has relationships with insurers.

State-by-State Snapshot: Where You Can Practice

California

• NPs: AB 890 pathway allows independent practice after 3 years in a physician-led group (104 NP status by 2026)
• Telehealth: Strong parity laws; private insurers must cover telehealth at same rate as in-person
• Prescribing: No state-specific caps; must check CURES (CA PDMP) every 4 months for ongoing controlled Rx
• Market: High demand, especially in Central Valley and Inland Empire; tech-savvy patient base open to digital health

Texas

• NPs: Restricted practice; requires physician Prescriptive Authority Agreement with monthly meetings
• Telehealth: HB 1052 (2026) ensures coverage for out-of-state providers with TX license
• Prescribing: NPs cannot prescribe Schedule II outpatient; Schedule IV insomnia meds allowed under delegation
• Market: Massive rural underserved areas (West Texas, Panhandle); high demand but NP barriers add overhead

Florida

• NPs: Restricted; psychiatric NPs excluded from autonomous practice law, need MD supervision
• Telehealth: Out-of-state providers can register without full FL license; 7-day Schedule II limit for NPs
• Prescribing: Schedule IV sleep meds fine; psych use exempts Schedule II telehealth ban
• Market: Large elderly population with insomnia; long wait times for psychiatrists create opportunity

New York

• NPs: Full practice after 3,600 hours; collaboration required before that
• Telehealth: Strong coverage mandates; Medicaid reimburses audio-only for mental health
• Prescribing: Must check I-STOP PDMP for every controlled Rx; no unusual caps
• Market: NYC has high demand; upstate underserved; strong telehealth adoption statewide

Pennsylvania

• NPs: Restricted; requires collaboration with 2 physicians; 30-day Schedule II, 90-day Schedule III/IV caps
• Telehealth: No formal parity law; coverage varies by insurer
• Prescribing: NP limits apply to telehealth; MDs unrestricted
• Market: 500,000+ residents in mental health shortage areas; high need, but NP barriers complicate scalability

Illinois

• NPs: Full practice authority after 4,000 hours + 250 CE hours; collaboration required initially
• Telehealth: Permanent payment parity law (2021); covers in-home telehealth
• Prescribing: FPA NPs can prescribe independently (Schedule II >30 days needs MD consult)
• Market: Chicago metro saturated but downstate (Peoria, Rockford, Springfield) underserved

Practical Workflow: What a Telehealth Insomnia Visit Looks Like

Initial Consultation (30 minutes):

1. History: Detailed sleep history (onset, duration, sleep diary), psychiatric comorbidities (depression, anxiety), medical history, current medications, substance use
2. Screening: STOP-BANG for sleep apnea risk, Epworth Sleepiness Scale, rule out restless legs
3. Assessment: Differentiate primary insomnia from secondary causes; evaluate for CBT-I candidacy
4. Treatment Plan: Discuss medication options (zolpidem, trazodone, doxepin), risks/benefits, expectations
5. Prescribe: If appropriate, prescribe 30-day supply with clear instructions (take 30 min before bed, avoid alcohol, taper plan if used nightly)
6. Coordinate: Refer to digital CBT-I app or therapist; recommend sleep hygiene handout
7. PDMP Check: Document checking state prescription monitoring database
8. Follow-Up: Schedule 2-week check-in to assess efficacy and side effects

Follow-Up Visits (15-20 minutes):

• Review sleep diary: improved sleep latency/duration?
• Side effects: morning grogginess, sleep-walking, memory issues?
• Adjust dose or switch medication if needed
• Reassess need for ongoing pharmacotherapy vs tapering
• Address underlying issues (anxiety, depression) if present
• Bill as 99213 (20 min) or 99214 (30 min)

Documentation Must Include:

• Patient location during telehealth visit
• Telehealth consent obtained
• PDMP check performed (date/time)
• Clinical rationale for controlled substance
• Discussed risks, alternatives, and taper plan
• Coordinated care with PCP or sleep specialist if applicable

Why Providers Choose Platforms Like Klarity for Insomnia Care

Building a telehealth insomnia practice from scratch is doable, but it’s expensive and slow. Here’s why many providers choose a platform model instead:

1. Pre-Qualified Patient Flow

You’re not competing for directory clicks or burning ad dollars hoping someone books. Patients matched to you have already been screened for insurance, appropriateness, and scheduling fit. Higher conversion, less wasted time.

2. Zero Marketing Risk

No $5,000/month Google Ads gamble. No SEO waiting game. You pay per appointment, so your cost per patient is fixed and predictable.

3. Built-In Compliance

PDMP checks, e-prescribing, telehealth consent forms, state-specific documentation — all handled within the platform. You’re not cobbling together separate EMR, billing, and telehealth tools.

4. Insurance + Cash Mix

Most platforms offer both insurance credentialing (if you want it) and cash-pay options. You control your payor mix without managing billing internally.

5. Supervision Arrangements (for NPs in Restricted States)

If you’re a PMHNP in Texas or Florida and need a collaborating physician, many platforms provide those relationships as part of their infrastructure. You don’t have to find and contract with a supervising MD yourself.

6. Flexibility

Set your own schedule. See patients evenings or weekends. Scale up or down based on your availability. No overhead, no office lease, no staff payroll.

For established providers: Platforms like Klarity are a way to fill open slots or expand into new states without the administrative headache of setting up multi-state licensure, billing, and marketing infrastructure yourself.

For newer providers: It’s a way to build a caseload quickly without gambling thousands of dollars on unproven marketing tactics.

FAQ: Insomnia Prescribing via Telehealth

Can I prescribe Ambien to a new patient via telehealth without ever meeting them in person?

Yes, as of early 2026. The DEA’s extended flexibilities allow prescribing controlled substances like zolpidem via telehealth without a prior in-person visit. You must conduct a video visit (audio-only is insufficient), document the encounter thoroughly, check your state’s PDMP, and ensure you’re licensed in the patient’s state.

Do I need to check the PDMP every time I prescribe insomnia meds?

It depends on your state. Texas requires PDMP checks for benzodiazepines and opioids (so yes for temazepam, no strict requirement for zolpidem but recommended). New York mandates checking I-STOP for every controlled substance prescription. Illinois focuses on opioids and benzos. Best practice: check the PDMP for all controlled meds every time.

Can PMHNPs prescribe insomnia medications independently?

In full practice authority states (New York after 3,600 hours, California after AB 890 transition, Illinois after 4,000 hours), yes — PMHNPs can prescribe independently. In restricted states (Texas, Florida, Pennsylvania), you need a collaborating physician. Check your state’s scope of practice laws.

What if the patient has sleep apnea symptoms?

Don’t prescribe a hypnotic. Sleep apnea is a contraindication for many sedatives (they can worsen airway obstruction). Refer for a sleep study (polysomnography) or home sleep apnea test. Coordinate with their PCP or a sleep medicine specialist. Telehealth is great for triage, but you can’t diagnose sleep apnea via video.

How long should I prescribe insomnia meds for?

Initial prescription: 30 days. Follow up in 2-4 weeks to assess efficacy and side effects. If the patient improves, discuss tapering and transitioning to non-pharmacologic strategies (CBT-I, sleep hygiene). Chronic insomnia meds (beyond 3-6 months) should prompt reassessment of underlying causes and consideration of alternatives. Some states (Pennsylvania for NPs) have statutory limits on prescription duration.

What if a patient wants a refill but I suspect misuse?

Review the PDMP for overlapping prescriptions from other providers. Ask about dose escalation, running out early, or using meds differently than prescribed. If you suspect misuse, do not refill. Offer non-controlled alternatives (trazodone, doxepin, CBT-I referral) and discuss substance use treatment if appropriate. Document your clinical reasoning thoroughly.

Can I prescribe insomnia meds to patients in multiple states?

Only if you’re licensed in each state where the patient is located during the telehealth visit. Some states (Florida) allow out-of-state provider registration. Others require full licensure. The IMLC (for physicians) makes multi-state licensing easier in member states. Check licensure requirements before treating patients across state lines.

Do insurers cover telehealth for insomnia medication management?

Yes. Most insurers cover tele-mental health visits, and 24 states have payment parity laws requiring reimbursement at the same rate as in-person visits. Medicare reimburses telehealth psychiatry visits equivalently. Prior authorization requirements for controlled substances apply regardless of visit modality.

Next Steps: Start Treating Insomnia via Telehealth

If you’re a psychiatrist or PMHNP looking to expand your practice, insomnia care via telehealth is a high-demand, clinically rewarding niche. Patients desperately need help, reimbursement is solid, and the regulatory environment (while complex) is navigable with the right setup.

Before you start:

1. Verify your state’s scope of practice rules. Make sure you understand whether you can prescribe independently or need a collaborating physician.

2. Get licensed in your target states. If you’re focusing on multiple states, start the licensure process early (it can take months). Consider the IMLC if you’re a physician.

3. Set up PDMP access. Register for your state’s prescription monitoring program and any states where you’ll be practicing.

4. Choose your practice model. Will you build your own telehealth practice (higher overhead, slower patient acquisition) or join a platform like Klarity (lower risk, faster ramp-up)?

5. Brush up on insomnia treatment guidelines. Review CBT-I protocols, medication options, and deprescribing strategies. Insomnia care is more nuanced than ‘here’s Ambien, see you in a month.’

Ready to see patients without the patient acquisition gamble?

Klarity Health connects psychiatrists and PMHNPs with pre-qualified patients seeking insomnia treatment and other psychiatric care. No upfront marketing costs. No wasted ad spend. Just real patients ready to book appointments.

Explore opportunities with Klarity and start building your telehealth insomnia practice today.

Sources and References

1. California Board of Registered Nursing – AB 890 Implementation
   www.rn.ca.gov/practice/ab890.shtml
   Official state board guidance on California’s NP independent practice pathway (103/104 NP categories). Updated 2024.

2. Texas Medical Board – APRN Prescribing and Supervision FAQs
   www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision
   Texas requirements for prescriptive authority agreements, supervision, and Schedule II prescribing restrictions. Current as of 2019 law (accessed February 2026).

3. Rivkin Rounds Law Blog – New Law Allows Experienced NPs to Practice Independently in NY
   www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny
   Analysis of New York’s 2022 legislation making experienced NPs independent after 3,600 hours. Published April 13, 2022.

4. Commonwealth Foundation – Nurse Practitioner Reform: Full Practice Authority in Pennsylvania
   commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania
   Details Pennsylvania’s restrictive NP rules including 2-physician collaboration requirement and prescribing duration limits. Published December 5, 2022.

5. Center for Connected Health Policy (CCHP) – State Telehealth Laws and Reimbursement Policies Report: Fall 2025
   www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025
   Comprehensive state-by-state telehealth policy summary including payment parity, coverage requirements, and modality regulations. Published October 2025.

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025